Concepedia

Zhandong Don Zhong

ZD

Statistics

Publications

14

Citations

492

H-Index

13

Active since

1990

Affiliations

Amgen (United States)(Current)

University of Utah

Takeda (United States)

Regeneron (United States)

Pfizer (United States)

Zhandong Don Zhong is an author at Amgen (United States) specializing in chemistry, organometallic chemistry, and organic chemistry.

Publications per year

1990–2022

14

Publications

14

Phase 1 Study of AMG 386, a Selective Angiopoietin 1/2–Neutralizing Peptibody, in Combination with Chemotherapy in Adults with Advanced Solid Tumors

Alain C. Mita, Chris H. Takimoto, Monica Mita et al. · Clinical Cancer Research · 2010 · 101 citations

, , +16

Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies

Zhandong Don Zhong, Adrienne Clements‐Egan, Boris Gorovits et al. · The AAPS Journal · 2017 · 84 citations · Full text

, , +17

Identification and inhibition of drug target interference in immunogenicity assays

Zhandong Don Zhong, Steve Dinnogen, Martha Hokom et al. · Journal of Immunological Methods · 2010 · 62 citations

, , +13

Acyclic Cp(CO)2Fe Disubstituted .eta.1-Vinylidene-.eta.2-Acetylene Isomerizations

Robert S. Bly, Zhandong Don Zhong, Cathal Kane et al. · Organometallics · 1994 · 39 citations

, , +8

Development of a biosensor-based immunogenicity assay capable of blocking soluble drug target interference

Dohan Weeraratne, James A. Lofgren, Steve Dinnogen et al. · Journal of Immunological Methods · 2013 · 36 citations

, , +14

1–5 of 14